The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting applications for the NINDS Human Biospecimen and Data Repository, a cooperative agreement aimed at managing and expanding a collection of biospecimens for neurological disorder research. The repository, known as BioSEND, will facilitate the distribution of high-quality, well-annotated biospecimens to academic and industry researchers, supporting basic, translational, and clinical research efforts. This initiative emphasizes the importance of scientific expertise, ethical considerations, and a sustainability plan in biobanking operations, with a total funding amount of up to $1,950,000 available for a maximum project period of five years. Interested applicants must submit their proposals by March 9, 2026, and can direct inquiries to NINDS-BRAC@ninds.nih.gov.
Eligible Applicants
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.